Peter G. Bardy

Adelaide, SA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Long-Term Survival Gains after Allogeneic Hematopoietic Stem Cell Transplant are Driven by Reductions in Non-Relapse Mortality: A 35-Year Statewide Australian Cohort Study.

Long-Term Survival Gains after Allogeneic Hematopoietic Stem Cell Transplant are Driven by Reductions in Non-Relapse Mortality: A 35-Year Statewide Australian Cohort Study.

Journal: Transplantation and cellular therapy

Published: November 13, 2025

Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort.

Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort.

Journal: Blood cancer journal

Published: December 27, 2024

Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations.

Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations.

Journal: Blood advances

Published: November 04, 2024

Outcomes of allogeneic haemopoietic transplant for chronic lymphocytic leukaemia in the modern era.

Outcomes of allogeneic haemopoietic transplant for chronic lymphocytic leukaemia in the modern era.

Journal: Internal medicine journal

Published: May 04, 2024

Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion.

Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion.

Journal: Blood advances

Published: December 04, 2023

Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular Therapies.

Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular Therapies.

Journal: Transplantation and cellular therapy

Published: August 04, 2023

Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study.

Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study.

Journal: Transplantation and cellular therapy

Published: January 23, 2023

Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study.

Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study.

Journal: Bone marrow transplantation

Published: December 01, 2022

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.

Journal: Blood

Published: September 06, 2022

Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches.

Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: July 10, 2022

Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell.

Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell.

Journal: Internal medicine journal

Published: May 17, 2022

Novel modes of MPL activation in triple-negative myeloproliferative neoplasms.

Novel modes of MPL activation in triple-negative myeloproliferative neoplasms.

Journal: Pathology

Published: February 14, 2022

Showing 1-12 of 40

Last Updated: 09/26/2026